Healthcare -
Biotechnology - NASDAQ - US
$ 1.36
0 %
$ 87.4 M
Market Cap
-0.88
P/E
INZY - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities INZY - Inozyme Pharma, Inc.
126 M
LAST VALUE
1338.21%
2 YEAR CAGR
31.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR